Regulation of innate and adaptive immunity by Notch

Nature Reviews Immunology

Volumn 13, Issue 6, 2013, Pages 427-437

  Radtke, Freddy ^a   MacDonald, H Robson ^b   Tacchini Cottier, Fabienne ^b  

^a EPFL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84878245626     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3445     Document Type: Review

References (119)

1. Morgan, T. H. The theory of the gene. Am. Nat. 51, 513-544 (1917).
2. Bray, S. J. Notch signalling: a simple pathway becomes complex. Nature Rev. Mol. Cell Biol. 7, 678-689 (2006).
3. Kopan, R. & Ilagan, M. X. G. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233 (2009).
4. Poellinger, L. & Lendahl, U. Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms. Curr. Opin. Genet. Dev. 18, 449-454 (2008).
5. Samon, J. B. et al. Notch1 and TGFβ1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 112, 1813-1821 (2008).
6. Heitzler, P. Biodiversity and noncanonical Notch signaling. Curr. Top. Dev. Biol. 92, 457-481 (2010).
7. Palomero, T. et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc. Natl Acad. Sci. USA 103, 18261-18266 (2006).
8. Weng, A. P. et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 20, 2096-2109 (2006).
9. Iso, T., Kedes, L. & Hamamori, Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell. Physiol. 194, 237-255 (2003).
10. Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547-558 (1999).
11. Han, H. et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14, 637-645 (2002).
12. Pui, J. C. et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11, 299-308 (1999).
13. Koch, U. et al. Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity 15, 225-236 (2001).
14. Izon, D. J. et al. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity 16, 231-243 (2002).
15. Yun, T. J. & Bevan, M. J. Notch-regulated ankyrin-repeat protein inhibits Notch1 signaling: multiple Notch1 signaling pathways involved in T cell development. J. Immunol. 170, 5834-5841 (2003).
16. Maillard, I. et al. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood 104, 1696-1702 (2004).
17. Wilson, A., MacDonald, H. R. & Radtke, F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194, 1003-1012 (2001).
18. Bell, J. J. & Bhandoola, A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452, 764-767 (2008).
19. Wada, H. et al. Adult T-cell progenitors retain myeloid potential. Nature 452, 768-772 (2008).
20. Feyerabend, T. B. et al. Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsic mechanisms. Immunity 30, 67-79 (2009).
21. Wendorff, A. A. et al. Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation. Immunity 33, 671-684 (2010).
22. Jaleco, A. C. et al. Differential effects of Notch ligands 5-1 and Jagged-1 in human lymphoid differentiation. J. Exp. Med. 194, 991-1002 (2001).
23. Schmitt, T. M. & Zuniga-Pflucker, J. C. Induction of T cell development from hematopoietic progenitor cells by δ-like-1 in vitro. Immunity 17, 749-756 (2002).
24. Hozumi, K. et al. δ-like 4 is indispensable in thymic environment specific for T cell development. J. Exp. Med. 205, 2507-2513 (2008).
25. Koch, U. et al. δ-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J. Exp. Med. 205, 2515-2523 (2008).
26. Mohtashami, M. et al. Direct comparison of Dll1-and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes. J. Immunol. 185, 867-876 (2010).
27. Taghon, T., Yui, M. A., Pant, R., Diamond, R. A. & Rothenberg, E. V. Developmental and molecular characterization of emerging β-and yô-selected pre-T cells in the adult mouse thymus. Immunity 24, 53-64 (2006).
28. Van de Walle, I. et al. An early decrease in Notch activation is required for human TCR-aβ lineage differentiation at the expense of TCR-yδ T cells. Blood 113, 2988-2998 (2009).
29. Taghon, T. et al. Notch signaling is required for proliferation but not for differentiation at a well-defined β-selection checkpoint during human T-cell development. Blood 113, 3254-3263 (2009).
30. Yashiro-Ohtani, Y. et al. Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A. Genes Dev. 23, 1665-1676 (2009).
31. Pillai, S. & Cariappa, A. The follicular versus marginal zone B lymphocyte cell fate decision. Nature Rev. Immunol. 9, 767-777 (2009).
32. Balazs, M., Martin, F., Zhou, T. & Kearney, J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17, 341-352 (2002).
33. Hozumi, K. et al. δ-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nature Immunol. 5, 638-644 (2004).
34. Saito, T. et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18, 675-685 (2003).
35. Tanigaki, K. et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nature Immunol. 3, 443-450 (2002).
36. Oyama, T. et al. Mastermind-1 is required for Notch signal-dependent steps in lymphocyte development in vivo. Proc. Natl Acad. Sci. USA 104, 9764-9769 (2007).
37. Wu, L., Maillard, I., Nakamura, M., Pear, W. S. & Griffin, J. D. The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development. Blood 110, 3618-3623 (2007).
38. Song, R. et al. Mind bomb 1 in the lymphopoietic niches is essential for T and marginal zone B cell development. J. Exp. Med. 205, 2525-2536 (2008).
39. Gibb, D. R. et al. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J. Exp. Med. 207, 623-635 (2010).
40. Kuroda, K. et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 18, 301-312 (2003).
41. Tan, J. et al. Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for δ-like 1 in splenic endothelial niches. Immunity 30, 254-263 (2009).
42. Caton, M. L., Smith-Raska, M. R. & Reizis, B. Notch-RBP-J signaling controls the homeostasis of CD8-dendritic cells in the spleen. J. Exp. Med. 204, 1653-1664 (2007).
43. Lewis, K. L. et al. Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 35, 780-791 (2011).
44. Radtke, F. et al. Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J. Exp. Med. 191, 1085-1094 (2000).
45. + plasmacytoid dendritic cells develop independently of the T-cell lineage. Blood 100, 2852-2857 (2002).
46. Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647-675 (2012).
47. Spits, H. et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nature Rev. Immunol. 13, 145-149 (2013).
48. Spits, H. & Di Santo, J. P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nature Immunol. 12, 21-27 (2011).
49. Cherrier, M., Sawa, S. & Eberl, G. Notch, Id2, and RORγt sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J. Exp. Med. 209, 729-740 (2012).
50. + cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
51. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282-289 (2008).
52. Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565 (2011).
53. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629-640 (2011).
54. Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nature Immunol. 13, 144-151 (2012).
55. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology Nature 464, 1371-1375 (2010).
56. Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
57. Price, A. E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl Acad. Sci. USA 107, 11489-11494 (2010).
58. Wong, S. H. et al. Transcription factor RORa is critical for nuocyte development. Nature Immunol. 13, 229-236 (2012).
59. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
60. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol. 6, 1123-1132 (2005).
61. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
62. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
63. Veldhoen, M. et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nature Immunol. 9, 1341-1346 (2008).
64. + Foxp3-effector T cells. Nature Immunol. 9, 1347-1355 (2008).
65. Johnston, R. J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006-1010 (2009).
66. Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001-1005 (2009).
67. + T cells. Science 327, 1098-1102 (2010).
68. + T cell transcription factors. Nature Rev. Immunol. 12, 799-804 (2012).
69. H2 effector cells made? Curr. Opin. Immunol. 21, 153-160 (2009).
70. Radtke, F., Fasnacht, N. & Macdonald, H. R. Notch signaling in the immune system. Immunity 32, 14-27 (2010).
71. + T helper cells. Curr. Top. Microbiol. Immunol. 360, 115-134 (2012).
72. Amsen, D. et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117, 515-526 (2004).
73. Amsen, D., Antov, A. & Flavell, R. A. The different faces of Notch in T-helper-cell differentiation. Nature Rev. Immunol. 9, 116-124 (2009).
74. Minter, L. M. et al. Inhibitors of y-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nature Immunol. 6, 680-688 (2005).
75. Jurynczyk, M., Jurewicz, A., Raine, C. S. & Selmaj, K. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. J. Immunol. 180, 2634-2640 (2008).
76. Fang, T. C. et al. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27, 100-110 (2007).
77. Tu, L. et al. Notch signaling is an important regulator of type 2 immunity. J. Exp. Med. 202, 1037-1042 (2005).
78. Auderset, F et al. Redundant Notch1 and Notch2 signaling is necessary for IFNy secretion by T helper 1 cells during infection with Leishmania major. PLoS Pathog. 8, e1002560 (2012).
79. Palaga, T, Miele, L, Golde, T. E. & Osborne, B. A. TCR-mediated notch signaling regulates proliferation and IFN-y production in peripheral T cells. J. Immunol. 171, 3019-3024 (2003).
80. Shin, H. M. et al. Notch1 augments NF-KB activity by facilitating its nuclear retention. EMBO J. 25, 129-138 (2006).
81. Amsen, D. et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 27, 89-99 (2007).
82. Tanaka, S. et al. The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells. Immunity 24, 689-701 (2006).
83. Zheng, W & Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
84. Elyaman, W et al. Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 36, 623-634 (2012).
85. H17 cytokines in autoimmune neuro-inflammation. Curr. Opin. Immunol. 23, 707-712 (2011).
86. + regulatory T cells. Nature Rev. Immunol. 11, 119-130 (2011).
87. Anastasi, E. et al. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J. Immunol. 171, 4504-4511 (2003).
88. Campese, A. F et al. Notch3 and pTa/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells. Int. Immunol. 21, 727-743 (2009).
89. Barbarulo, A. et al. Notch3 and canonical NF-KB signaling pathways cooperatively regulate Foxp3 transcription. J. Immunol. 186, 6199-6206 (2011).
90. Kared, H. et al. Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. Immunity 25, 823-834 (2006).
91. Bassil, R. et al. Notch ligand δ-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development. J. Immunol. 187, 2322-2328 (2011).
92. Elyaman, W et al. JAGGED1 and δ1 differentially regulate the outcome of experimental autoimmune encephalomyelitis. J. Immunol. 179, 5990-5998 (2007).
93. Billiard, F et al. Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice. J. Exp. Med. 209, 1011-1028 (2012).
94. Rao, P. E., Petrone, A. L. & Ponath, P. D. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174, 1446-1455 (2005).
95. + T cells. Int. Immunol. 12, 177-185 (2000).
96. Vigouroux, S. et al. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes. J. Virol. 77, 10872-10880 (2003).
97. Asano, N., Watanabe, T., Kitani, A., Fuss, I. J. & Strober, W Notch1 signaling and regulatory T cell function. J. Immunol. 180, 2796-2804 (2008).
98. Del Papa, B. et al. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction. Eur. J. Immunol. 43, 182-187 (2012).
99. Haque, R. et al. Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity. J. Immunol. 189, 1228-1236 (2012).
100. + cell-dependent mechanism. J. Clin. Invest. 112, 1741-1750 (2003).
101. Maekawa, Y et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nature Immunol. 9, 1140-1147 (2008).
102. Riella, L. V et al. Blockade of Notch ligand δ1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation. J. Immunol. 187, 4629-4638 (2011).
103. Sugimoto, K. et al. Notch2 signaling is required for potent antitumor immunity in vivo. J. Immunol. 184, 4673-4678 (2010).
104. + T cells. J. Immunol. 182, 3380-3389 (2009).
105. + T cells. Blood 121, 2638-2646 (2013).
106. Welniak, L. A., Blazar, B. R. & Murphy, W J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu. Rev. Immunol. 25, 139-170 (2007).
107. + T-cell responses mediating graft-versus-host disease. Blood 117, 299-308 (2011).
108. Tran, I. T. et al. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J. Clin. Invest. 123, 1590-1604 (2013).
109. Toubai, T. et al. Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease. Blood 118, 192-204 (2011).
110. Dumortier, A. et al. Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol. Cell. Biol. 26, 209-220 (2006).
111. Gomez-del Arco, P. et al. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity 33, 685-698 (2010).
112. Wolfe, M. S. y-secretase inhibitors as molecular probes of presenilin function. J. Mol. Neurosci. 17, 199-204 (2001).
113. Haltiwanger, R. S. & Stanley, P. Modulation of receptor signaling by glycosylation: fringe is an O-fucose-β 1, 3-N- acetylglucosaminyltransferase. Biochim. Biophys. Acta 1573, 328-335 (2002).
114. Bruckner, K., Perez, L, Clausen, H. & Cohen, S. Glycosyltransferase activity of Fringe modulates Notch-0 interactions. Nature 406, 411-415 (2000).
115. Yang, L. T. et al. Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by 51 and Jagged1. Mol. Biol. Cell 16, 927-942 (2005).
116. Besseyrias, V et al. Hierarchy of Notch-0 interactions promoting T cell lineage commitment and maturation. J. Exp. Med. 204, 331-343 (2007).
117. Baxter, A. G. The origin and application of experimental autoimmune encephalomyelitis. Nature Rev. Immunol. 7, 904-912 (2007).
118. Takeichi, N. et al. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int. Immunol. 22, 729-738 (2010).
119. Reynolds, N. D., Lukacs, N. W., Long, N. & Karpus, W J. δ-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis. J. Immunol. 187, 2803-2813 (2011).